ICD-10 Specific code D25: Leiomyoma of uterus
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Leiomyoma of uterus |
French
|
Léiomyome de l'utérus |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | II | Neoplasms | |
| 2 | D10-D36 | Benign neoplasms | |
| 3 | D25 | Leiomyoma of uterus |
Contents
| Code | Title | |
|---|---|---|
| D25.0 | Submucous leiomyoma of uterus | |
| D25.1 | Intramural leiomyoma of uterus | |
| D25.2 | Subserosal leiomyoma of uterus | |
| D25.9 | Leiomyoma of uterus, unspecified |
Indicated medicines
| Active Ingredient |
|---|
|
Linzagolix is a selective, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signalling by binding competitively to GnRH receptors in the pituitary gland, thereby modulating the hypothalamic-pituitary-gonadal axis. |